Pioglitazone Adjunctive Therapy for Moderate-to-Severe Major Depressive Disorder: Randomized Double-Blind Placebo-Controlled Trial

Achieving Remission and Favorable Outcomes in Patients with Depression/Anxiety and Substance use Disorders

(2016) Alan F. Schatzberg   CNS SPECTRUMS

Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study

(2011) A. John Rush et al.   AMERICAN JOURNAL OF PSYCHIATRY

Rosiglitazone and Pioglitazone for the Treatment of Alzheimer's Disease

(2011) Benjamin W Miller et al.   ANNALS OF PHARMACOTHERAPY

Antidepressant-like effect of pioglitazone in the forced swimming test in mice: The role of PPAR-gamma receptor and nitric oxide pathway

(2011) Mohammad Salehi Sadaghiani et al.   BEHAVIOURAL BRAIN RESEARCH

Lithium, phenserine, memantine and pioglitazone reverse memory deficit and restore phospho-GSK3β decreased in hippocampus in intracerebroventricular streptozotocin induced memory deficit model

(2011) Teresa Ponce-Lopez et al.   BRAIN RESEARCH

Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression

(2011) Roya Abolfazli et al.   DEPRESSION AND ANXIETY

Ketogenic diet-induced peroxisome proliferator-activated receptor-γ activation decreases neuroinflammation in the mouse hippocampus after kainic acid-induced seizures

(2011) Eun Ae Jeong et al.   EXPERIMENTAL NEUROLOGY

Use of insulin sensitizers for the treatment of major depressive disorder: A pilot study of pioglitazone for major depression accompanied by abdominal obesity

(2011) David E. Kemp et al.   JOURNAL OF AFFECTIVE DISORDERS

Protein levels of β-catenin and activation state of glycogen synthase kinase-3β in major depression. A study with postmortem prefrontal cortex

(2011) Félicien Karege et al.   JOURNAL OF AFFECTIVE DISORDERS

Exercise as an Augmentation Treatment for Nonremitted Major Depressive Disorder

(2011) Madhukar H. Trivedi et al.   JOURNAL OF CLINICAL PSYCHIATRY

Rosiglitazone Add-On in Treatment of Depressed Patients with Insulin Resistance: a Pilot Study

(2011) Natalie L. Rasgon et al.   TheScientificWorldJOURNAL

Citalopram for major depressive disorder in adults: a systematic review and meta-analysis of published placebo-controlled trials

(2011) A. Apler   BMJ Open

A Randomized Pilot Clinical Trial of the Safety of Pioglitazone in Treatment of Patients With Alzheimer Disease

(2010) David S. Geldmacher et al.   ARCHIVES OF NEUROLOGY

Is there a role for the nuclear receptor PPARγ in neuropsychiatric diseases?

(2010) Borja García-Bueno et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Improvement within 2weeks and later treatment outcomes in patients with depressive disorders: The CRESCEND study

(2010) Jae-Min Kim et al.   JOURNAL OF AFFECTIVE DISORDERS

Hypoglycaemia with pioglitazone: analysis of data from the Prescription-Event Monitoring study

(2010) Veronika Vlckova et al.   JOURNAL OF EVALUATION IN CLINICAL PRACTICE

Antidepressant Response Associated With Pioglitazone: Support for an Overlapping Pathophysiology Between Major Depression and Metabolic Syndrome

(2009) DAVID E. KEMP et al.   AMERICAN JOURNAL OF PSYCHIATRY

Combination of Antidepressant Medications From Treatment Initiation for Major Depressive Disorder: A Double-Blind Randomized Study

(2009) Pierre Blier et al.   AMERICAN JOURNAL OF PSYCHIATRY

Antidepressant-like effects of rosiglitazone, a PPARγ agonist, in the rat forced swim and mouse tail suspension tests

(2009) Amany Ali Eissa Ahmed et al.   BEHAVIOURAL PHARMACOLOGY

Stress-induced neuroinflammation: mechanisms and new pharmacological targets

(2009) C.D. Munhoz et al.   BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial

(2009) Shahin Akhondzadeh et al.   DEPRESSION AND ANXIETY

Mirtazapine and paroxetine in major depression: A comparison of monotherapy versus their combination from treatment initiation

(2009) Pierre Blier et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder

(2009) Ronald N. Marcus et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

A pilot test of pioglitazone as an add-on in patients with relapsing remitting multiple sclerosis

(2009) Claudia C. Kaiser et al.   JOURNAL OF NEUROIMMUNOLOGY

Does early improvement triggered by antidepressants predict response/remission? — Analysis of data from a naturalistic study on a large sample of inpatients with major depression

(2008) Verena Henkel et al.   JOURNAL OF AFFECTIVE DISORDERS

Time course of response to antidepressants: Predictive value of early improvement and effect of additional psychotherapy

(2008) Dietrich van Calker et al.   JOURNAL OF AFFECTIVE DISORDERS

Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice

(2008) Angelo O. Rosa et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY